首页> 外文期刊>Acta biomaterialia >Novel tricalcium silicate/magnesium phosphate composite bone cement having high compressive strength, in vitro bioactivity and cytocompatibility
【24h】

Novel tricalcium silicate/magnesium phosphate composite bone cement having high compressive strength, in vitro bioactivity and cytocompatibility

机译:具有高抗压强度,体外生物活性和细胞相容性的新型硅酸三钙/磷酸镁复合骨水泥

获取原文
获取原文并翻译 | 示例
           

摘要

Although inorganic bone cements such as calcium phosphate cements have been widely applied in orthopaedic and dental fields because of their self-setting ability, development of high-strength bone cement with bioactivity and biodegradability remains a major challenge. Therefore, the purpose of this study is to prepare a tricalcium silicate/magnesium phosphate (C3S/MPC) composite bone cement, which is intended to combine the excellent bioactivity of C3S with remarkable self-setting properties and mechanical strength of MPC. The self-setting and mechanical properties, in vitro induction of apatite formation and degradation behaviour, and cytocompatibility of the composite cements were investigated. Our results showed that the C3S/MPC composite cement with an optimal composition had compressive strength up to 87 MPa, which was significantly higher than C3S (25 MPa) and MPC (64 MPa). The setting time could be adjusted between 3 min and 29 min with the variation of compositions. The hydraulic reaction products of the C3S/MPC composite cement were composed of calcium silicate hydrate (CSH) derived from the hydration of C3S and gel-like amorphous substance. The C3S/MPC composite cements could induce apatite mineralization on its surface in SBF solution and degraded gradually in Tris-HCl solution. Besides, the composite cements showed good cytocompatibility and stimulatory effect on the proliferation of MC3T3-E1 osteoblast cells. Our results indicated that the C3S/MPC composite bone cement might be a new promising high-strength inorganic bioactive material which may hold the potential for bone repair in load-bearing site. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
机译:尽管诸如磷酸钙水泥之类的无机骨水泥由于其自凝能力已被广泛应用于整形外科和牙科领域,但是开发具有生物活性和生物可降解性的高强度骨水泥仍然是主要挑战。因此,本研究的目的是制备硅酸三钙/磷酸镁(C3S / MPC)复合骨水泥,该水泥旨在将C3S的出色生物活性与卓越的自固化性能和MPC的机械强度相结合。研究了复合水泥的自凝定性和力学性能,体外诱导的磷灰石形成和降解行为以及细胞相容性。我们的结果表明,具有最佳组成的C3S / MPC复合水泥的抗压强度高达87 MPa,显着高于C3S(25 MPa)和MPC(64 MPa)。凝结时间可以根据组成的不同在3分钟至29分钟之间进行调整。 C3S / MPC复合水泥的水硬反应产物由水合硅酸钙(CSH)和凝胶状无定形物质组成。 C3S / MPC复合水泥可在SBF溶液中诱导其表面磷灰石矿化,并在Tris-HCl溶液中逐渐降解。复合水泥对MC3T3-E1成骨细胞的增殖具有良好的细胞相容性和刺激作用。我们的结果表明,C3S / MPC复合骨水泥可能是一种新的有前途的高强度无机生物活性材料,它可能在承重部位具有修复骨的潜力。 (C)2015 Acta Materialia Inc.,由Elsevier Ltd.发行。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号